Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page. This is a minor version control update and does not alter study content, eligibility criteria, outcomes, or enrollment details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded 'Familial multiple polyposis syndrome' and removed 'Classic familial adenomatous polyposis' from the page terminology. The update aligns disease terminology with current references without changing any study details.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3. This is a versioning update and does not affect study content or user-facing features.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3. This is a metadata change rather than a modification to the main content.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision: v3.4.2. Removed the Notice about lapse in government funding and the prior Revision: v3.4.1.SummaryDifference0.5%

- Check75 days agoChange DetectedAdded a government funding status notice. Updated the page to revision v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.